Seelos Therapeutics Inc (SEEL)
0.2775
0.00 (0.00%)
USD |
NASDAQ |
Apr 30, 16:00
0.2775
0.00 (0.00%)
After-Hours: 19:54
Seelos Therapeutics Cash and Short Term Investments (Quarterly): 2.996M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.996M |
September 30, 2023 | 2.584M |
June 30, 2023 | 5.843M |
March 31, 2023 | 14.06M |
December 31, 2022 | 15.53M |
September 30, 2022 | 30.51M |
June 30, 2022 | 41.25M |
March 31, 2022 | 61.77M |
December 31, 2021 | 78.73M |
September 30, 2021 | 76.83M |
June 30, 2021 | 87.20M |
March 31, 2021 | 38.69M |
December 31, 2020 | 15.66M |
September 30, 2020 | 8.054M |
June 30, 2020 | 5.854M |
March 31, 2020 | 12.69M |
December 31, 2019 | 10.26M |
September 30, 2019 | 15.32M |
June 30, 2019 | 9.728M |
March 31, 2019 | 11.29M |
December 31, 2018 | 3.579M |
September 30, 2018 | 5.283M |
June 30, 2018 | 6.836M |
March 31, 2018 | 5.678M |
December 31, 2017 | 6.331M |
Date | Value |
---|---|
September 30, 2017 | 8.463M |
June 30, 2017 | 7.821M |
March 31, 2017 | 3.762M |
December 31, 2016 | 2.087M |
September 30, 2016 | 5.614M |
June 30, 2016 | 2.723M |
March 31, 2016 | 6.907M |
December 31, 2015 | 3.887M |
September 30, 2015 | 5.809M |
June 30, 2015 | 7.433M |
March 31, 2015 | 16.16M |
December 31, 2014 | 11.40M |
September 30, 2014 | 16.11M |
June 30, 2014 | 17.42M |
March 31, 2014 | 22.49M |
December 31, 2013 | 21.40M |
September 30, 2013 | 20.62M |
June 30, 2013 | 24.76M |
March 31, 2013 | 14.10M |
December 31, 2012 | 15.13M |
September 30, 2012 | 16.86M |
June 30, 2012 | 17.94M |
March 31, 2012 | 21.53M |
December 31, 2011 | 7.435M |
September 30, 2011 | 8.878M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.584M
Minimum
Sep 2023
87.20M
Maximum
Jun 2021
28.08M
Average
15.32M
Median
Sep 2019
Cash and Short Term Investments (Quarterly) Benchmarks
180 Life Sciences Corp | 1.976M |
Acurx Pharmaceuticals Inc | 7.474M |
NovaBay Pharmaceuticals Inc | 3.13M |
Palatin Technologies Inc | 9.485M |
iBio Inc | 2.788M |